TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CopenHeartVR - A Randomized Clinical Trial Investigating the Effect of Integrated Rehabilitation Versus Usual Care Without Physical Exercise After Heart Valve Surgery.
Brief Summary: The aim of the study is to investigate the effect of an integrated rehabilitation programme, consisting of physical exercise training and psycho-educational consultations, for patients after heart valve surgery.

The hypothesis is that integrated rehabilitation can improve physical capacity measured by V02 peak, self-rated mental health and life quality by validated questionnaires such as SF-36, and other objective parameters such as cardiac-specific biomarkers and echocardiographic measurements.


Options:
A: Arm Label: CABG control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PACO intervention for CABG patients; Type: EXPERIMENTAL; Interventions: Behavioral: PACO intervention for CABG patients | Arm Label: AVR control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PACO intervention for AVR patients; Type: EXPERIMENTAL; Interventions: Behavioral: PACO intervention for AVR patients | Arm Label: MVR control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PACO intervention for MVR patients; Type: EXPERIMENTAL; Interventions: Behavioral: PACO intervention for MVR patients | Intervention Type: BEHAVIORAL; Name: PACO intervention for CABG patients; Assigned to Arm(s): PACO intervention for CABG patients | Intervention Type: BEHAVIORAL; Name: PACO intervention for AVR patients; Assigned to Arm(s): PACO intervention for AVR patients | Intervention Type: BEHAVIORAL; Name: PACO intervention for MVR patients; Assigned to Arm(s): PACO intervention for MVR patients
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Integrated rehabilitation | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated rehabilitation; Assigned to Arm(s): Intervention group
C: Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
D: Arm Label: Cardiac Rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Cardiac Rehabilitation | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cardiac Rehabilitation; Assigned to Arm(s): Cardiac Rehabilitation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double Blinded Placebo-Controlled Trial on the Routine Use of Preoperative Antibiotic Prophylaxis in Modified Radical Mastectomy
Brief Summary: This is a randomized, double blinded, placebo-controlled trial on the routine use of preoperative antibiotic prophylaxis in modified radical mastectomy to evaluate the efficacy of preoperative prophylactic antibiotics in the prevention of surgical site infection (SSI) in patients undergoing modified radical mastectomy (MRM) for breast care.


Options:
A: Arm Label: Antibiotics until Drain Removal; Type: OTHER; Interventions: Drug: Cefadroxil until drain removal | Arm Label: Early discontinuation of antibiotics; Type: EXPERIMENTAL; Interventions: Drug: Cefadroxil discontinued early | Intervention Type: DRUG; Name: Cefadroxil discontinued early; Assigned to Arm(s): Early discontinuation of antibiotics | Intervention Type: DRUG; Name: Cefadroxil until drain removal; Assigned to Arm(s): Antibiotics until Drain Removal
B: Arm Label: Treatment Arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cefazolin | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sterile water | Intervention Type: PROCEDURE; Name: Cefazolin; Assigned to Arm(s): Treatment Arm | Intervention Type: PROCEDURE; Name: Sterile water; Assigned to Arm(s): Placebo Arm
C: Arm Label: Gentamicin lavage; Type: EXPERIMENTAL; Interventions: Drug: Axillary lavage with gentamicin solution | Arm Label: Normal saline lavage; Type: ACTIVE_COMPARATOR; Interventions: Drug: Axillary lavage with gentamicin solution | Intervention Type: DRUG; Name: Axillary lavage with gentamicin solution; Assigned to Arm(s): Gentamicin lavage, Normal saline lavage
D: Arm Label: Prophylaxis Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ampicillin/Sulbactam | Arm Label: No Prophylaxis Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Ampicillin/Sulbactam; Assigned to Arm(s): Prophylaxis Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Comparison of a Low Fat or Low Carbohydrate Dietary Pattern for Weight Loss and Impact on Biomarkers Associated With Breast Cancer Risk in Overweight and Obese Premenopausal Women: Lifestyle Eating and Fitness
Brief Summary: The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.


Options:
A: Arm Label: Low Fat Diet + Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Fat Diet plus exercise | Arm Label: Low Carbohydrate Diet + Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Carbohydrate diet + Exercise | Intervention Type: BEHAVIORAL; Name: Low Fat Diet plus exercise; Assigned to Arm(s): Low Fat Diet + Exercise | Intervention Type: BEHAVIORAL; Name: Low Carbohydrate diet + Exercise; Assigned to Arm(s): Low Carbohydrate Diet + Exercise
B: Intervention Type: BEHAVIORAL; Name: Four Diets Differing in Macronutrient Composition; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Diets Low in Saturated Fat; Assigned to Arm(s): N/A
C: Arm Label: DIPI: Danish national dietary guidelines; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: DIPI: Specific IHD dietary guideline; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: Normal dietary habits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: DIPI; Assigned to Arm(s): DIPI: Danish national dietary guidelines, DIPI: Specific IHD dietary guideline
D: Arm Label: High MUFA diet; Type: EXPERIMENTAL; Interventions: Other: High-MUFA diet | Arm Label: High CHO diet; Type: ACTIVE_COMPARATOR; Interventions: Other: High-CHO diet | Intervention Type: OTHER; Name: High-MUFA diet; Assigned to Arm(s): High MUFA diet | Intervention Type: OTHER; Name: High-CHO diet; Assigned to Arm(s): High CHO diet

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients
Brief Summary: Chronic pain patients are treated with prescription opioids and many exhibit opioid addiction. Currently, there are no evidence-based guidelines to better manage patients with chronic pain and coexistent opioid addiction. This study compares 6-months buprenorphine and methadone treatment in these patients. The investigators hypothesize that both buprenorphine and methadone treatment will reduce pain and addiction behaviors and increase functioning in these patients.


Options:
A: Arm Label: 1-week buprenorphine taper; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine taper followed by naltrexone maintenance, Behavioral: Behavioral therapy | Arm Label: 2-week buprenorphine taper; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine taper followed by naltrexone maintenance, Behavioral: Behavioral therapy | Arm Label: 4-week buprenorphine taper; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine taper followed by naltrexone maintenance, Behavioral: Behavioral therapy | Intervention Type: DRUG; Name: buprenorphine taper followed by naltrexone maintenance; Assigned to Arm(s): 1-week buprenorphine taper, 2-week buprenorphine taper, 4-week buprenorphine taper | Intervention Type: BEHAVIORAL; Name: Behavioral therapy; Assigned to Arm(s): 1-week buprenorphine taper, 2-week buprenorphine taper, 4-week buprenorphine taper
B: Arm Label: Buprenorphine/Nx with EMM; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Medical Management (EMM) of Prescription Opiate Abuse | Arm Label: Buprenorphine/Nx with SMM; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Medical Management (SMM) of Prescription Opiate Abuse | Intervention Type: BEHAVIORAL; Name: Standard Medical Management (SMM) of Prescription Opiate Abuse; Assigned to Arm(s): Buprenorphine/Nx with SMM | Intervention Type: BEHAVIORAL; Name: Enhanced Medical Management (EMM) of Prescription Opiate Abuse; Assigned to Arm(s): Buprenorphine/Nx with EMM
C: Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Arm Label: Buprenorphine/naloxone; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine/naloxone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): Buprenorphine/naloxone
D: Arm Label: Extended-Release Naltrexone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Extended-Release Naltrexone | Arm Label: Buprenorphine-Naloxone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Buprenorphine-Naloxone | Intervention Type: DRUG; Name: Extended-Release Naltrexone; Assigned to Arm(s): Extended-Release Naltrexone | Intervention Type: DRUG; Name: Buprenorphine-Naloxone; Assigned to Arm(s): Buprenorphine-Naloxone

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Service members and veterans often experience symptoms of psychological trauma following combat deployments. While efforts are being made in the military and at the Veteran's Affairs to meet the large number of soldiers and veterans experiencing symptoms of psychological trauma, there remains a need to evaluate new treatments, particularly those that are designed to be brief in length.

A new therapy, known as Accelerated Resolution Therapy (ART), is a type of psychological therapy that is designed for rapid resolution of symptoms of psychological trauma. This approach uses a combination of talking and sets of eye movements guided by the therapist. During therapy, this interactive personal guidance is thought to be helpful in resolving problems (such as bad memories).

The purpose of this study is to:

1. Evaluate how effective ART is in treating symptoms of psychological trauma among non-active duty veterans who served in Operation Iraqi Freedom and Operation Enduring Freedom in Iraq and in Afghanistan or other combat conflicts.
2. Learn if there is improvement in symptoms of psychological trauma (such as bad memories, anxiety, depression, and guilt) after receiving Accelerated Resolution Therapy (ART).


Options:
A: Arm Label: Lifespan Integration; Type: EXPERIMENTAL; Interventions: Other: Lifespan Integration | Arm Label: Waiting list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Lifespan Integration; Assigned to Arm(s): Lifespan Integration
B: Arm Label: ART therapy group; Type: EXPERIMENTAL; Interventions: Behavioral: Accelerated Resolution Therapy (ART) | Arm Label: Waitlist; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Waitlist | Intervention Type: BEHAVIORAL; Name: Accelerated Resolution Therapy (ART); Assigned to Arm(s): ART therapy group | Intervention Type: BEHAVIORAL; Name: Waitlist; Assigned to Arm(s): Waitlist
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy, Behavioral: Hypnosis | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Hypnosis; Assigned to Arm(s): 2
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present-Centered Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Present-Centered Therapy; Assigned to Arm(s): Arm 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Two Lengths of Treatment in Early-onset Ventilated Associated Pneumonia
Brief Summary: The duration of treatment of community acquired pulmonary infection varies between 5 and 14 days according to the authors (22), or even 3 days with new drugs having long half-life (2). For nosocomial pulmonary infection, treatment durations are not standardized (5). It is simply mentioned the concept of "usual" treatment of at least 15 days. However, recent studies used 10 days of treatment without significant decrease in the rate of healing compared to usual treatment. It is essential to clarify the optimal duration of antibiotic treatment. Indeed, any excessive extension of treatment may increase the occurrence of adverse effects (renal toxicities, hepatic...), and induce resistance of bacteria to antibiotics (selection pressure), colonization of the patient by Multiresistant bacteria and an increase in the cost of treatment


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Amikacin (BAY41-6551) | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Amikacin (BAY41-6551) | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Amikacin (BAY41-6551); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Amikacin (BAY41-6551); Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3
B: Arm Label: 8 days of antibiotic treatment; Type: EXPERIMENTAL; Interventions: Drug: Augmentin, Ceftriaxone, Cefotaxime, netilmycin, tobramycin, Drug: compare 8 to15 days of antibiotic treatment | Arm Label: 15 days antibiotic treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: compare 8 to15 days of antibiotic treatment | Intervention Type: DRUG; Name: Augmentin, Ceftriaxone, Cefotaxime, netilmycin, tobramycin; Assigned to Arm(s): 8 days of antibiotic treatment | Intervention Type: DRUG; Name: compare 8 to15 days of antibiotic treatment; Assigned to Arm(s): 15 days antibiotic treatment, 8 days of antibiotic treatment
C: Arm Label: Doripenem; Type: EXPERIMENTAL; Interventions: Drug: Doripenem, Drug: Placebo | Arm Label: Imipenem-Cilastatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Imipenem-Cilastatin, Drug: Placebo | Intervention Type: DRUG; Name: Doripenem; Assigned to Arm(s): Doripenem | Intervention Type: DRUG; Name: Imipenem-Cilastatin; Assigned to Arm(s): Imipenem-Cilastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Doripenem, Imipenem-Cilastatin
D: Arm Label: PCT guided; Type: EXPERIMENTAL; Interventions: Procedure: Earlier therapeutic changes regarding infection | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Earlier therapeutic changes regarding infection | Intervention Type: PROCEDURE; Name: Earlier therapeutic changes regarding infection; Assigned to Arm(s): Control, PCT guided

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Brief Summary: This study will evaluate the long-term efficacy and safety of low dose oral methylprednisolone compared to matching placebo, on a background of routine RAS inhibitor therapy, in preventing kidney events in patients with IgA nephropathy and features suggesting a high risk of progression.


Options:
A: Intervention Type: DRUG; Name: prednisone + Inhibace/Cozaar; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Inhibace/Cozaar; Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: supportive therapy with: ACE-inhibitor / ARB / Statin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: supportive and immunosuppressive therapy | Intervention Type: DRUG; Name: supportive therapy with: ACE-inhibitor / ARB / Statin; Assigned to Arm(s): A | Intervention Type: DRUG; Name: supportive and immunosuppressive therapy; Assigned to Arm(s): B
C: Arm Label: NEFECON 8 mg/day; Type: EXPERIMENTAL; Interventions: Drug: NEFECON | Arm Label: NEFECON 16 mg/day; Type: EXPERIMENTAL; Interventions: Drug: NEFECON | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: NEFECON; Assigned to Arm(s): NEFECON 16 mg/day, NEFECON 8 mg/day | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: oral methylprednisolone; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylprednisolone | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: methylprednisolone; Assigned to Arm(s): oral methylprednisolone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Validation of a Structured Training and Assessment Curriculum (STAC) for Technical Skill Acquisition in Minimally Invasive Surgery. A Randomized Controlled Study
Brief Summary: This study describes the development and validation of a structured training and assessment curriculum (STAC) for a basic laparoscopic procedure. The investigators hypothesized that residents trained using the STAC curriculum would demonstrate superior technical skills in the operating room compared to residents that were trained using a traditional curriculum.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: simulator training | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: simulator training | Intervention Type: DEVICE; Name: simulator training; Assigned to Arm(s): 1, 2
B: Arm Label: Progressive Group; Type: EXPERIMENTAL; Interventions: Behavioral: Progressive Group | Arm Label: High-Fidelity Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Progressive Group; Assigned to Arm(s): Progressive Group
C: Arm Label: Curriculum Group; Type: EXPERIMENTAL; Interventions: Behavioral: Curriculum Group | Arm Label: Self-directed learning group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-directed learning group | Intervention Type: BEHAVIORAL; Name: Curriculum Group; Assigned to Arm(s): Curriculum Group | Intervention Type: BEHAVIORAL; Name: Self-directed learning group; Assigned to Arm(s): Self-directed learning group
D: Arm Label: STAC curriculum; Type: EXPERIMENTAL; Interventions: Other: STAC curriculum | Arm Label: Conventional Curriculum; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: STAC curriculum; Assigned to Arm(s): STAC curriculum

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) - a Randomised, Doubleblinded and Placebocontrolled Trial of Men With Subnormal Testosterone Levels and T2DM.
Brief Summary: A randomized, placebo-controlled, double-blinded study on 40 men with type 2 DM.

Type 2 diabetes mellitus (T2DM) is a common endocrine disorder characterized by hyperinsulinaemia and insulin resistance.

Hypothesis Testosterone therapy increases lean body mass and insulin sensitivity in men with low normal levels of bioavailable testosterone and type 2 DM.


Options:
A: Arm Label: AndroGel 1.62%; Type: ACTIVE_COMPARATOR; Interventions: Drug: AndroGel® | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AndroGel®; Assigned to Arm(s): AndroGel 1.62% | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Testim; Type: ACTIVE_COMPARATOR; Interventions: Drug: Testosterone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Testosterone; Assigned to Arm(s): Testim | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Drug: Topical testosterone gel 1% (active formulation) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Topical gel (placebo formulation) | Intervention Type: DRUG; Name: Topical testosterone gel 1% (active formulation); Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Topical gel (placebo formulation); Assigned to Arm(s): Placebo
D: Arm Label: Placebo Solution; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Solution | Arm Label: Testosterone Solution; Type: EXPERIMENTAL; Interventions: Drug: Testosterone Solution | Intervention Type: DRUG; Name: Testosterone Solution; Assigned to Arm(s): Testosterone Solution | Intervention Type: DRUG; Name: Placebo Solution; Assigned to Arm(s): Placebo Solution

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A School-based Internet Obesity Prevention Program for Adolescents
Brief Summary: Compare the effect of the HEALT\[e\]TEEN program and a HEALTH\[e\]TEEN plus coping skills training delivered to high school students on BMI, nutrition and physical activity behaviors, and self-efficacy over 6 months.


Options:
A: Arm Label: HEALTH[e]TEEN; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HEALTH[e]TEEN | Arm Label: HEALTH[e]TEEN + CST; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HEALTH[e]TEEN + CST | Intervention Type: BEHAVIORAL; Name: HEALTH[e]TEEN; Assigned to Arm(s): HEALTH[e]TEEN | Intervention Type: BEHAVIORAL; Name: HEALTH[e]TEEN + CST; Assigned to Arm(s): HEALTH[e]TEEN + CST
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Experimental | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Experimental; Assigned to Arm(s): 1
C: Arm Label: Kids SipSmartER; Type: EXPERIMENTAL; Interventions: Behavioral: Kids SipSmartER | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Kids SipSmartER; Assigned to Arm(s): Kids SipSmartER
D: Arm Label: Obesity prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity Prevention | Arm Label: Tobacco prevention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tobacco Prevention | Intervention Type: BEHAVIORAL; Name: Obesity Prevention; Assigned to Arm(s): Obesity prevention | Intervention Type: BEHAVIORAL; Name: Tobacco Prevention; Assigned to Arm(s): Tobacco prevention

Answer: A